aDepartment of Cardiology, UK
bNational Poisons Information Service - Edinburgh, Royal Infirmary of Edinburgh, UK
cClinical Pharmacology Unit, Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK
Correspondence to Michael Eddleston, Clinical Pharmacology Unit, QMRI E3.20, 47 Little France Crescent, Edinburgh, EH16 4TJ, UK E-mail: [email protected]
Editor: R E Ferner, MSc, MD, FRCP, Director of the West Midlands Centre for Adverse Drug Reaction Reporting and Consultant Physician at City Hospital, Birmingham, UK. Assistant Editor: Mr C Anton, MA, MEng. Editorial Board: Australia: Dr M Kennedy, Professor G M Shenfield, Denmark: Professor J S Schou; England: Dr J K Aronson; Ireland: Professor J Feely; Netherlands: Professor C J van Boxtel, Dr B H Ch Stricker; New Zealand: Dr T Maling; Scotland: Dr D N Bateman; Wales: Professor P A Routledge.
